Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rational design of next-generation vaccine adjuvants: From molecular mechanisms to hybrid delivery platforms. | Hum Vaccin Immunother | 2026 | 41837360 | PubTator, text mining | PubMed |
| Enucleated cells with Nectin-1 overexpression capture HSV-1 and promote viral elimination for herpes simplex encephalitis therapy. | Cell Rep | 2026 | 41824450 | PubTator, text mining | PubMed |
| Host-targeted oral avian vaccine virus demonstrates broad antiviral activity and safety in patients. | Front Immunol | 2026 | 41822497 | PubTator, text mining | PubMed |
| Acute-on-chronic liver failure and immune dysregulation: Systemic inflammation and immunoparesis paradox. | Hepatol Commun | 2026 | 41812001 | PubTator, text mining | PubMed |
| Drug-associated insomnia and sex-specific disproportionality in the FDA adverse event reporting system (2019-Q1 2025). | Front Pharmacol | 2026 | 41808869 | PubTator, text mining | PubMed |
| Protein-level profiling of TIGIT axis components in human PDAC reveals immune-suppressive expression patterns. | Cancer Immunol Immunother | 2026 | 41805925 | PubTator, text mining | PubMed |
| QT-related adverse events with ondansetron and olanzapine: a real-world FAERS analysis with implications for oncology anti-emetic practice. | Front Pharmacol | 2026 | 41800097 | PubTator, text mining | PubMed |
| Implications and prospects of immunological and neuroimaging research in HIV-associated neurocognitive disorders. | Front Neurol | 2026 | 41798804 | PubTator, text mining | PubMed |
| Data mining and analysis of adverse drug events of propofol in the general population and the elderly based on the US Food and Drug Administration Adverse Event Reporting System. | Medicine (Baltimore) | 2026 | 41790687 | PubTator, text mining | PubMed |
| Analysis of Human miRNA Derived From Bladder Epithelial Cells Infected With Uropathogenic Escherichia coli. | APMIS | 2026 | 41773809 | PubTator, text mining | PubMed |
| Z-DNA binding protein 1 mediates necroptotic cell death in primary murine microglia following herpes simplex virus-1 infection. | J Neurovirol | 2026 | 41772241 | PubTator, text mining | PubMed |
| Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers. | Ann Hematol | 2026 | 41770372 | PubTator, text mining | PubMed |
| A real-world study of ublituximab based on the WHO-VigiAccess and U.S. food and drug administration's adverse event reporting system databases. | Front Immunol | 2026 | 41766879 | PubTator, text mining | PubMed |
| Thromboembolic adverse events associated with TPO-RA in ITP treatment: a pharmacovigilance analysis of the FDA Adverse Event Reporting System. | Front Immunol | 2026 | 41766870 | PubTator, text mining | PubMed |
| A real-world pharmacovigilance study of bempedoic acid plus ezetimibe fixed-dose combination based on the FDA FAERS database. | Medicine (Baltimore) | 2026 | 41760008 | PubTator, text mining | PubMed |
| A Murine Model of HSV-1-Induced Corneal Endotheliitis: Primary Infection, Latency, and Recurrence. | Invest Ophthalmol Vis Sci | 2026 | 41757823 | PubTator, text mining | PubMed |
| Advances in delivery technologies-powered cancer vaccines. | Bioact Mater | 2026 | 41756688 | PubTator, text mining | PubMed |
| Host Cell Receptor and Herpes Simplex Virus 1 Glycoprotein B Are Determinants of Low Temperature Entry. | Viruses | 2026 | 41754506 | PubTator, text mining | PubMed |
| Rethinking Disease Control in Aquaculture Invertebrates: Harnessing Innate Immunity in Molluscs and Crustaceans. | Pathogens | 2026 | 41754421 | PubTator, text mining | PubMed |
| Early Transcriptomic Response of Human Iris Stromal Cells During Herpes Simplex Virus Entry Reveals Interplay Between Cell Glycocalyx and Viral Exploitation. | Int J Mol Sci | 2026 | 41751906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=3